Recursion Pharmaceuticals Inc (RXRX) — Tangible Net Worth Ratio
Recursion Pharmaceuticals Inc (RXRX) has a Tangible Net Worth Ratio of 71.3% as of March 2026. This metric is calculated by deducting intangible assets ($294.07 Million) from net assets ($1.02 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is Recursion Pharmaceuticals Inc's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Recursion Pharmaceuticals Inc Tangible Net Worth Ratio (2021–2025)
This chart shows how Recursion Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 71.3%, reflecting net assets of $1.02 Billion with intangible assets of $294.07 Million USD. Also explore RXRX net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Recursion Pharmaceuticals Inc (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Recursion Pharmaceuticals Inc from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Recursion Pharmaceuticals Inc (RXRX) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.6% | $1.13 Billion | $309.90 Million | $1.47 Billion | ▲ +5.1 pp |
| 2024 | 67.5% | $1.03 Billion | $335.86 Million | $1.45 Billion | ▼ -24.6 pp |
| 2023 | 92.1% | $463.44 Million | $36.44 Million | $653.70 Million | ▼ -7.6 pp |
| 2022 | 99.7% | $485.81 Million | $1.31 Million | $701.29 Million | ▼ 0.0 pp |
| 2021 | 99.7% | $542.94 Million | $1.39 Million | $610.35 Million | — |